Deep geno- and phenotyping in two consanguineous families with CMT2 reveals HADHA as an unusual disease-causing gene and an intronic variant in GDAP1 as an unusual mutation

[1]  M. Reilly,et al.  Charcot-Marie-Tooth disease and related disorders: an evolving landscape. , 2019, Current opinion in neurology.

[2]  S. Efthymiou,et al.  Continuum of phenotypes in hereditary motor and sensory neuropathy with proximal predominance and Charcot–Marie–Tooth patients with TFG mutation , 2019, American journal of medical genetics. Part A.

[3]  Anirudh Gupta,et al.  Charcot-Marie-Tooth: From Molecules to Therapy , 2019, International journal of molecular sciences.

[4]  R. Horvath,et al.  HADHA and HADHB gene associated phenotypes - Identification of rare variants in a patient cohort by Next Generation Sequencing. , 2019, Molecular and cellular probes.

[5]  Byung-Ok Choi,et al.  Clinical and genetic aspects of Charcot-Marie-Tooth disease subtypes , 2019, Precision and Future Medicine.

[6]  Rui Wu,et al.  HADHB mutations cause infantile-onset axonal Charcot-Marie-Tooth disease: A report of two cases. , 2018, Clinical neuropathology.

[7]  R. Carlier,et al.  WES homozygosity mapping in a recessive form of Charcot-Marie-Tooth neuropathy reveals intronic GDAP1 variant leading to a premature stop codon , 2018, neurogenetics.

[8]  J. Weis,et al.  Hereditary Neuropathies. , 2018, Deutsches Arzteblatt international.

[9]  A. Kochański,et al.  A role for the GDAP 1 gene in the molecular pathogenesis of Charcot ‐ Marie ‐ Tooth disease , 2018 .

[10]  A. Kochański,et al.  A role for the GDAP1 gene in the molecular pathogenesis of Charcot‑Marie‑Tooth disease. , 2018, Acta neurobiologiae experimentalis.

[11]  F. Baas,et al.  Pseudodominant inheritance pattern in a family with CMT2 caused by GDAP1 mutations , 2017, Journal of the peripheral nervous system : JPNS.

[12]  P. Nunes,et al.  Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review , 2016, Neuroepidemiology.

[13]  J. Lupski,et al.  Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy. , 2015, Cell reports.

[14]  J. Vallat,et al.  Charcot–Marie–Tooth diseases: an update and some new proposals for the classification , 2015, Journal of Medical Genetics.

[15]  M. Shy,et al.  Hereditary motor and sensory neuropathies: Understanding molecular pathogenesis could lead to future treatment strategies. , 2015, Biochimica et biophysica acta.

[16]  R. Munita,et al.  A comprehensive survey of non-canonical splice sites in the human transcriptome , 2014, Nucleic acids research.

[17]  W. Schobersberger,et al.  Sports in LCHAD Deficiency: Maximal Incremental and Endurance Exercise Tests in a 13-Year-Old Patient with Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase Deficiency (LCHADD) and Heptanoate Treatment. , 2014, JIMD reports.

[18]  H. Koo,et al.  A compound heterozygous mutation in HADHB gene causes an axonal Charcot-Marie-tooth disease , 2013, BMC Medical Genetics.

[19]  T. Liewluck,et al.  Mitochondrial trifunctional protein deficiency: A rare cause of adult‐onset rhabdomyolysis , 2013, Muscle & nerve.

[20]  J. Polke,et al.  Clinical implications of genetic advances in Charcot–Marie–Tooth disease , 2013, Nature Reviews Neurology.

[21]  A. Munnich,et al.  Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency. , 2011, Molecular genetics and metabolism.

[22]  D. Bonneau,et al.  Mitochondrial dysfunction and pathophysiology of Charcot–Marie–Tooth disease involving GDAP1 mutations , 2011, Experimental Neurology.

[23]  M. Shy,et al.  Charcot‐marie‐tooth disease subtypes and genetic testing strategies , 2011, Annals of neurology.

[24]  M. Baumgartner,et al.  Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop , 2009, Journal of Inherited Metabolic Disease.

[25]  M. Baumgartner,et al.  Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop , 2009, Journal of Inherited Metabolic Disease.

[26]  J. Lupski,et al.  Charcot-Marie-Tooth disease and related hereditary polyneuropathies: Molecular diagnostics determine aspects of medical management , 2006, Genetics in Medicine.

[27]  Axel Niemann,et al.  Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network , 2005, The Journal of cell biology.

[28]  Xingyao Wu,et al.  GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria. , 2005, Human molecular genetics.

[29]  M. Bennett,et al.  Peripheral neuropathy, episodic myoglobinuria, and respiratory failure in deficiency of the mitochondrial trifunctional protein , 2004, Muscle & nerve.

[30]  S. Mellgren,et al.  Hereditary Neuropathies , 2019, Definitions.

[31]  M. Bennett,et al.  Molecular and phenotypic heterogeneity in mitochondrial trifunctional protein deficiency due to β‐subunit mutations , 2003 .

[32]  P. Rinaldo,et al.  Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. , 2003, Molecular genetics and metabolism.

[33]  M. Bennett,et al.  Molecular and phenotypic heterogeneity in mitochondrial trifunctional protein deficiency due to beta-subunit mutations. , 2003, Human mutation.

[34]  I. Marín,et al.  The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease , 2002, Nature Genetics.

[35]  J. Gilbert,et al.  Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21 , 2002, Nature Genetics.

[36]  R. Wanders,et al.  Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. , 1996, The Journal of clinical investigation.

[37]  I. Blair,et al.  Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: first report of a de novo duplication with a maternal origin. , 1996, American journal of human genetics.

[38]  X. Estivill,et al.  Estimation of the Mutation Frequencies in Charcot-Marie-Tooth Disease Type 1 and Hereditary Neuropathy with Liability to Pressure Palsies: A European Collaborative Study , 1996, European journal of human genetics : EJHG.

[39]  M. Bennett,et al.  Two alpha subunit donor splice site mutations cause human trifunctional protein deficiency. , 1995, The Journal of clinical investigation.

[40]  T Hashimoto,et al.  Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. II. Purification and properties of enoyl-coenzyme A (CoA) hydratase/3-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein. , 1992, The Journal of biological chemistry.